about
sameAs
Reducing the Social Gradient in Uptake of the NHS Colorectal Cancer Screening Programme Using a Narrative-Based Information Leaflet: A Cluster-Randomised Trial.The effect of cigarette smoking use and cessation on serum insulin-like growth factorsEuropean guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication.CT colonography in the detection of colorectal polyps and cancer: systematic review, meta-analysis, and proposed minimum data set for study level reporting.Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable.Attitudes to colorectal cancer screening among ethnic minority groups in the UK.Uptake of population-based flexible sigmoidoscopy screening for colorectal cancer: a nurse-led feasibility study.An ancestral Ashkenazi haplotype at the HMPS/CRAC1 locus on 15q13-q14 is associated with hereditary mixed polyposis syndromeOnce-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial.Microsatellite instability: application in hereditary non-polyposis colorectal cancer.Variables associated with the risk of colorectal adenomas in asymptomatic patients with a family history of colorectal cancerEarly diagnosis and prevention of sporadic colorectal cancer.Protagonist: population based endoscopic screening for colorectal cancer.Does publicity about cancer screening raise fear of cancer? Randomised trial of the psychological effect of information about cancer screening.Quality in the technical performance of screening flexible sigmoidoscopy: recommendations of an international multi-society task groupExon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndromeReview article: balancing the ideal versus the practical-considerations of colorectal cancer prevention and screening.Using a hypothetical scenario to assess public preferences for colorectal surveillance following screening-detected, intermediate-risk adenomas: annual home-based stool test vs. triennial colonoscopy.Socioeconomic variation in uptake of colonoscopy following a positive faecal occult blood test result: a retrospective analysis of the NHS Bowel Cancer Screening Programme.Review article: Population screening for colorectal cancer.Design of a multicentre randomized trial to evaluate CT colonography versus colonoscopy or barium enema for diagnosis of colonic cancer in older symptomatic patients: the SIGGAR studyImpact of general practice endorsement on the social gradient in uptake in bowel cancer screening.Prolonged biologically active colonic tissue levels of curcumin achieved after oral administration--a clinical pilot study including assessment of patient acceptability.Choosing between CT colonography and colonoscopy in the diagnostic context: a qualitative study of influences on patient preferences.Reducing the socioeconomic gradient in uptake of the NHS bowel cancer screening Programme using a simplified supplementary information leaflet: a cluster-randomised trial.The clinical effectiveness of different surveillance strategies to prevent colorectal cancer in people with intermediate-grade colorectal adenomas: a retrospective cohort analysis, and psychological and economic evaluations.A national cluster-randomised controlled trial to examine the effect of enhanced reminders on the socioeconomic gradient in uptake in bowel cancer screening.FOXE1 and SYNE1 genes hypermethylation panel as promising biomarker in colitis-associated colorectal neoplasia.Receiving a screen-detected diagnosis of cancer: the experience of participants in the UK flexible sigmoidoscopy trial.Recommendations From the International Colorectal Cancer Screening Network on the Evaluation of the Cost of Screening Programs.Terminal digit preference biases polyp size measurements at endoscopy, computed tomographic colonography, and histopathology.Ethnic differences in participation in flexible sigmoidoscopy screening in the UK.Computed tomographic colonography compared with colonoscopy or barium enema for diagnosis of colorectal cancer in older symptomatic patients: two multicentre randomised trials with economic evaluation (the SIGGAR trials).Perceived barriers to flexible sigmoidoscopy screening for colorectal cancer among UK ethnic minority groups: a qualitative study.The impact of individually-tailored lifestyle advice in the colorectal cancer screening context: a randomised pilot study in North-West London.Impending or pending? The national bowel cancer screening programme.Detection of malondialdehyde DNA adducts in human colorectal mucosa: relationship with diet and the presence of adenomas.CT colonography for diagnosis of symptomatic colorectal cancer: the SIGGAR trials and their implication for service delivery.Patient attitudes towards faecal immunochemical testing for haemoglobin as an alternative to colonoscopic surveillance of groups at increased risk of colorectal cancer.Mucinous carcinoma of the rectum.
P50
Q27313714-4BA1AE67-5E69-4414-8EFF-93FA4E47824DQ28212548-29B44449-3DD5-429C-A1CD-39AC6824F261Q30485842-2F8E32C2-9369-431A-BB1C-03B0B7CB7A96Q31020444-87D04F3C-E3A5-42A3-864E-92FF749DE86EQ31110735-EBBEEC07-31D2-4070-A3A3-D695F008AF69Q33316569-D6E4E8FD-4D23-4E5E-8555-C5D5B683FF44Q33633657-1E381AE0-FD66-4565-B893-321FC82537ECQ33904733-B67E1CC8-A3CA-4D9E-9802-092549DE47E5Q34112898-EA76D81A-3127-494B-B8FB-CBF341497795Q34217505-DA29FB7D-D0D7-44EE-A62B-1A5FBF630832Q34407693-6697E1C1-1F81-407D-BE65-DB47986272CAQ34461265-28C4BA9A-C604-4ECA-B40A-240F14044DC0Q35065312-DB908CDE-A133-4AA2-9F07-E43FD806DC7BQ35579072-32983C47-08C3-4EDD-B911-C808A75D5A63Q35597425-9418165E-7BC0-4A6F-98A9-1025D269EDA5Q35598109-D033B20D-E0F1-45E6-9F8F-35948DA1B77DQ35630078-63D645C2-16F4-4338-BB20-9DD44BD4EA16Q36130196-47C70E88-5BC0-4F62-9339-51FCCD2DFE99Q36184250-C4517EBF-0BB4-4DEF-BB00-F3452F272AEFQ36321324-35D72CB7-9F67-427A-B778-86C084A41869Q36326932-FA9FC187-F6E0-43A3-A7E6-E3F840FCFFAAQ36547880-1A8EFC8C-4B9F-4EBB-8FCC-E30576300CA8Q36592158-F9C71674-A505-4911-9E08-1765B3059BABQ37332385-D8A49AF9-FF11-497C-9F21-A3C09865AE5FQ38642738-25418069-6AF3-4370-BA63-D7F3C488B2EEQ38722575-5B418536-5202-4458-B740-EB10341C6699Q39163339-6F2050AC-27BA-4AE7-AF54-924549292413Q39306701-F66D4680-28D8-4EB7-BCCA-70BC6A74315AQ39386545-5EC18DE4-D840-4FD3-90F8-28114099EA86Q39538240-8EC3CFEA-5D72-491F-A9E8-2C0542C63F77Q39577144-CB51BB09-59C5-4D56-96DC-FC77A2945F66Q40035721-3DD58F1D-6543-4880-866D-77B910B0A02BQ40711346-89AB6DDD-1DCB-4940-99C9-0B3B5C0270E1Q42644942-A780E05E-BF0E-4841-A95E-C47D21B40FBBQ42857234-293962DC-F07B-4094-8FC3-B1F7DFF78FCAQ43256480-A2BA3CB1-9A7F-464D-8B60-486605B3380DQ43478740-1C5DA6EA-F148-4D64-BA8F-F1D48A8557FAQ43614147-D209C944-F256-4683-9C14-071D887CF602Q43620135-B6034F8D-309A-4010-BB7C-C29B7012F35EQ43652514-7BF8996D-3869-4827-9B09-99EEFDE63C57
P50
description
onderzoeker
@nl
scientist
@en
name
Wendy S Atkin
@ast
Wendy S Atkin
@en
Wendy S Atkin
@es
Wendy S Atkin
@nl
Wendy S Atkin
@sl
type
label
Wendy S Atkin
@ast
Wendy S Atkin
@en
Wendy S Atkin
@es
Wendy S Atkin
@nl
Wendy S Atkin
@sl
altLabel
Wendy Atkin
@en
Wendy Green
@en
Wendy S. Atkin
@en
Wendy S. Green
@en
Wendy Sheila Atkin
@en
Wendy Sheila Green
@en
prefLabel
Wendy S Atkin
@ast
Wendy S Atkin
@en
Wendy S Atkin
@es
Wendy S Atkin
@nl
Wendy S Atkin
@sl
P166
P214
P244
P101
P166
P19
P21
P214
P244
n2002136173
P31
P496
0000-0001-9073-9658
P569
1963-01-01T00:00:00Z
P570
2018-10-02T00:00:00Z
P734
P735
P7859
lccn-n2002136173